Phathom Pharmaceuticals (PHAT) Other Non Operating Income (2022 - 2025)
Historic Other Non Operating Income for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to -$7000.0.
- Phathom Pharmaceuticals' Other Non Operating Income rose 1250.0% to -$7000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$135000.0, marking a year-over-year decrease of 9014.08%. This contributed to the annual value of -$8000.0 for FY2024, which is 9574.47% up from last year.
- As of Q3 2025, Phathom Pharmaceuticals' Other Non Operating Income stood at -$7000.0, which was up 1250.0% from -$155000.0 recorded in Q2 2025.
- Phathom Pharmaceuticals' 5-year Other Non Operating Income high stood at $49000.0 for Q4 2024, and its period low was -$197000.0 during Q3 2023.
- For the 4-year period, Phathom Pharmaceuticals' Other Non Operating Income averaged around -$32666.7, with its median value being -$8000.0 (2024).
- Per our database at Business Quant, Phathom Pharmaceuticals' Other Non Operating Income surged by 45000.0% in 2024 and then tumbled by 248333.33% in 2025.
- Over the past 4 years, Phathom Pharmaceuticals' Other Non Operating Income (Quarter) stood at -$90000.0 in 2022, then soared by 84.44% to -$14000.0 in 2023, then soared by 450.0% to $49000.0 in 2024, then tumbled by 114.29% to -$7000.0 in 2025.
- Its Other Non Operating Income was -$7000.0 in Q3 2025, compared to -$155000.0 in Q2 2025 and -$22000.0 in Q1 2025.